Other OTC Pharmaceuticals - China

China

Highlights

In the year 2024, the revenue generated in the Other OTC Pharmaceuticals market in China amounted to US$2.50bn.
It is projected that this market will experience an annual growth rate of 1.87% (CAGR 2024-2029).
When compared to other countries worldwide, the highest revenue in the Other OTC Pharmaceuticals market is generated the United States, with a total of US$7.17bn in 2024.
In terms of per capita figures, in 2024, each person in China contributes US$1.75 in revenue to the Other OTC Pharmaceuticals market.
China's booming OTC Pharmaceuticals market is driven by an increasing demand for traditional Chinese medicine and herbal remedies.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in China is experiencing significant growth and development due to several key factors.

Customer preferences: Chinese consumers have shown a growing preference for self-medication and over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the increasing awareness and knowledge about healthcare and wellness, as well as the convenience and accessibility of OTC products. Many consumers prefer to treat minor ailments and symptoms on their own, rather than visiting a doctor or seeking prescription medication. This shift in consumer behavior has created a strong demand for Other OTC Pharmaceuticals in China.

Trends in the market: One major trend in the Other OTC Pharmaceuticals market in China is the increasing availability and variety of products. Both domestic and international pharmaceutical companies are expanding their product portfolios to cater to the growing demand. This includes a wide range of products such as pain relievers, cold and flu medications, digestive aids, and skincare products. Additionally, there is a growing trend towards natural and herbal remedies, as Chinese consumers place a high value on traditional medicine and natural ingredients.Another trend in the market is the rise of e-commerce platforms for purchasing OTC pharmaceutical products. Online platforms offer a convenient and efficient way for consumers to access a wide range of products, compare prices, and read reviews. This has further fueled the growth of the Other OTC Pharmaceuticals market in China, as consumers can easily purchase products from the comfort of their own homes.

Local special circumstances: China has a large population with increasing disposable income, which has contributed to the growth of the Other OTC Pharmaceuticals market. As more people have the means to afford healthcare products, the demand for OTC pharmaceuticals has increased. Additionally, the aging population in China is also driving the demand for OTC products, as older individuals often require medication for chronic conditions and age-related ailments.Furthermore, the Chinese government has implemented policies to encourage the development and growth of the domestic pharmaceutical industry. This includes initiatives to streamline the regulatory approval process for OTC products, as well as support for research and development in the sector. These policies have created a favorable environment for both domestic and international pharmaceutical companies to invest in the Other OTC Pharmaceuticals market in China.

Underlying macroeconomic factors: China's rapid economic growth and urbanization have contributed to the development of the Other OTC Pharmaceuticals market. As more people move to urban areas and have access to higher incomes, they are more likely to spend on healthcare products, including OTC pharmaceuticals. Additionally, the increasing middle class in China has led to a higher demand for quality healthcare products, driving the growth of the market.Overall, the Other OTC Pharmaceuticals market in China is experiencing significant growth due to changing customer preferences, the availability of a wide range of products, the rise of e-commerce platforms, local special circumstances such as a large population and aging population, and underlying macroeconomic factors such as rapid economic growth and urbanization.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.